Lubrizol Forms Alliance with Particle Sciences after Vesta Acquisition
The Lubrizol Corporation announces an alliance between Lubrizol LifeSciences and Particle Sciences. This alliance offers customers a comprehensive solution providing a range of materials, drug development and commercial manufacturing services that is one of the most comprehensive in the pharmaceutical industry.
Lubrizol’s recent acquisition of contract manufacturer Vesta, in combination with Lubrizol’s alliance with Particle Sciences, means that the LifeSciences business now offers complete solutions for sustained, controlled release and combination products from polymer supply and drug product development through quality manufacturing services. Lubrizol LifeSciences (booth 1817) will officially launch its alliance with Particle Sciences (booth 2911) at the American Association of Pharmaceutical Scientists (AAPS) conference 2–6 November at the San Diego Convention Center.
"We’ve broadened our offering and further reinforced our commitment to the pharmaceutical market," says Jean Claude Deneuville, Lubrizol LifeSciences director of the Pharma Solutions business. "By joining forces with Vesta and working with Particle Sciences, we have further expanded our set of skills and brought full-service solutions to the market." Lubrizol LifeSciences now offers a combination of world class polymer technology, drug product development services, clinical supply, applications know-how and commercial manufacturing.
"Teaming up with both Vesta and Particle Sciences enables Lubrizol to leverage our core polymer chemistry into tailored solutions for novel implantable and dermal drug delivery systems and combination products to deliver improved patient outcomes," says Joey Glassco, global market manager for Lubrizol LifeSciences.
The recent acquisition of Vesta broadens Lubrizol's life science manufacturing capabilities, applications and material portfolio with access to silicone polymers and a variety of thermoplastics utilised in medical devices, advanced wound care and drug eluting products such as subcutaneous implants and intravaginal rings. Headquartered in Franklin, WI, Vesta leverages over four decades of engineering expertise and manufacturing experience to service clinical device applications with the quality that customers trust.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance